December #130 : Free At Last - by Tim Murphy

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents
 

On the Cover-William 'Billy' Dickerson

35 Ones To Watch




High Definitions

Women on the Verge

Free At Last

Sins Of The Flesh

Poster Children

Trainer’s Bench-December 2006

Star Quality




Madonna Dearest

We’re Not In Kansas Anymore

Recipe for Disaster

Signing Bonus

Pick Your Poison

The Bug Stops Here




Editor's Letter-December 2006

Mailbox-December 2006

Catch Of The Month-December 2006



 
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV



email print

December 2006


Free At Last

by Tim Murphy

Why, after years of high viral loads, are some long-timers suddenly undetectable?

They’ve been hanging on, with daunting viral loads (VLs) and basement CD4 counts. But their lab tests have delivered an early holiday present: undetectable virus and climbing CD4s. This year, some longtime survivors, whose HIV developed resistance to most available meds, were presented with several powerful new drugs to try simultaneously. And hitting the virus with more than one new med at a time allows them to control HIV.

First, in June, the FDA approved the protease inhibitor (PI) Prezista (TMC-114). Meanwhile, the first integrase inhibitor, MK-0518, and a non-nuke, etravirine (TMC-125), became available through expanded access (ask your doctor). And another new lifeline is on the way: The entry inhibitor (EI) maraviroc should also offer such access early next year.

Houston’s Nelson Vergel, 47, a veteran advocate for the med-resistant, says we’re finally “at a tipping point.” Diagnosed in 1986, he’s never had an undetectable viral load and recently hit a CD4 low of 180. Four months after adding Prezista and MK-0518 to his old combo, his VL has vanished—and his CD4s have hit the 400s.J.D., 51, of Los Angeles, diagnosed in 1988, had a similar experience. Adding Prezista and etravirine to his regimen boosted his CD4s from the low 100s to 450. “I’m not undetectable yet,” he says—his VL hovers between 30,000 and 50,000—“but to go from ‘probably gonna die’ [including multiple hospitalizations] to over 400 T cells is amazing.”

Only future study data will determine what side effects- these meds may have, but so far, Vergel says, his sole MK-0518 side effect has been flatulence. “But with 414 T cells,” he says, “I’m happy to be gassy.”


[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Poll
Have you ever been diagnosed with diabetes or pre-diabetes?
Yes
No

Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.